Crescita Therapeutics Financials
| CRRTF Stock | USD 0.39 0.00 0.00% |
Crescita |
Understanding current and past Crescita Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Crescita Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Crescita Therapeutics' assets may result in an increase in income on the income statement.
Crescita Therapeutics Stock Summary
Crescita Therapeutics competes with Cannara Biotech, Knight Therapeutics, and HLS Therapeutics. Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. Crescita Therapeutics is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 2805 Place Louis-R |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.crescitatherapeutics.com |
| Phone | 905 673 4297 |
| Currency | USD - US Dollar |
Crescita Therapeutics Key Financial Ratios
There are many critical financial ratios that Crescita Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Crescita Therapeutics reports annually and quarterly.| Return On Equity | 0.0318 | |||
| Return On Asset | 0.0227 | |||
| Beta | 2.08 | |||
| Z Score | 3.6 |
Crescita Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Crescita Therapeutics's current stock value. Our valuation model uses many indicators to compare Crescita Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Crescita Therapeutics competition to find correlations between indicators driving Crescita Therapeutics's intrinsic value. More Info.Crescita Therapeutics is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.71 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Crescita Therapeutics is roughly 1.40 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Crescita Therapeutics' earnings, one of the primary drivers of an investment's value.Crescita Therapeutics Systematic Risk
Crescita Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Crescita Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Crescita Therapeutics correlated with the market. If Beta is less than 0 Crescita Therapeutics generally moves in the opposite direction as compared to the market. If Crescita Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Crescita Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Crescita Therapeutics is generally in the same direction as the market. If Beta > 1 Crescita Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Crescita Therapeutics March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Crescita Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Crescita Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Crescita Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Crescita Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Crescita Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 13.33 |
Complementary Tools for Crescita Pink Sheet analysis
When running Crescita Therapeutics' price analysis, check to measure Crescita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescita Therapeutics is operating at the current time. Most of Crescita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crescita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescita Therapeutics' price. Additionally, you may evaluate how the addition of Crescita Therapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |